MAPT and Alzheimer disease: It was further supported by DKK1 inhibitors such as antisense oligonucleotides (ASO) and IIIC3 (gallocyanine) that attenuated the neuronal apoptosis, and tau phosphorylation implies that DKK1 inhibition is a promising therapeutic target for the management of AD [102,103].